Clinical Practice Session
Heart Failure Across the Spectrum of CKD: Mechanisms and Treatment
November 07, 2025 | 10:30 AM - 12:30 PM
Location: Grand Ballroom B, Convention Center
Session Description
This session reviews new knowledge on mechanisms, diagnosis, and treatment of heart failure across the spectrum of kidney diseases, including recent drug studies on SGLT2 inhibitors, GLP-1 receptor agonists, and mineralocorticoid receptor antagonists.
ASN thanks the American Heart Association Council on the Kidney in Cardiovascular Disease for assistance with this session.
Learning Objective(s)
- Describe the epidemiology of heart failure and CKD
- Explain mechanisms of heart failure in persons with kidney diseases
- Summarize newer therapies in heart failure and CKD
- Discuss challenges in using guideline-directed medical therapy across the stages of CKD
- Describe treatment gaps for heart failure in kidney diseases
Learning Pathway(s)
- Hypertension and Cardiorenal Disorders
- CKD Non-Dialysis
Moderators
Presentations
- Kidney Diseases in Heart Failure: Burden of Disease and Pathophysiology
10:30 AM - 11:00 AM
- Considerations for Heart Failure Guideline-Directed Medical Therapy Across the Spectrum of CKD
11:00 AM - 11:30 AM
- Approaches to Heart Failure Diagnosis and Treatment in Dialysis and Kidney Transplant Recipients
11:30 AM - 12:00 PM
- Cardiorenal Syndrome: Key Priorities for the Next Decade
12:00 PM - 12:30 PM